A new control switch could make RNA therapies easier to program

Using an RNA sensor, MIT engineers have designed a new way to trigger cells to turn on a synthetic gene. Their approach could make it possible to create targeted therapies for cancer and other diseases, by ensuring that synthetic ...

New evolutionary insights from stepping outside the lab

Most of his career, Justin Crocker, EMBL Heidelberg Group Leader, has been working at the interface of development and evolution. In two new studies led by Crocker, scientists have shown how using non-standard laboratory ...

An electrochemical biosensor for antibody detection

The quantitative detection of specific antibodies in complex samples such as blood can provide information on many different diseases but usually requires a complicated laboratory procedure. A new method for the rapid, inexpensive, ...

AI tailors artificial DNA for future drug development

With the help of an AI, researchers at Chalmers University of Technology, Sweden, have succeeded in designing synthetic DNA that controls the cells' protein production. The technology can contribute to the development and ...

A review article clarifies genotype-independent plant transformation

Recently, researchers from North Carolina State University and the Beltsville Agricultural Research Center published the first review of research progress on genotype-independent plant transformation. In this review, researchers ...

page 2 from 8